Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CES2 | O00748 | 1/20 | 0.57 |
| ▸ | CES1 | P23141 | 1/20 | 0.57 |
| ▸ | CTNNB1 | P35222 | 2/20 | 0.56 |
| ▸ | WNT3A | P56704 | 2/20 | 0.56 |
| ▸ | DRD4 | P21917 | 5/20 | 0.55 |
| ▸ | DRD2 | P14416 | 2/20 | 0.55 |
| ▸ | NPC1 | O15118 | 1/20 | 0.55 |
| ▸ | POLB | P06746 | 1/20 | 0.55 |
| ▸ | RAB9A | P51151 | 1/20 | 0.55 |
| ▸ | BLM | P54132 | 1/20 | 0.55 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.55 |
| ▸ | PARP1 | P09874 | 1/20 | 0.54 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.52 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.52 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.52 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.52 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.51 |
| ▸ | LMNA | P02545 | 1/20 | 0.51 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.51 |
| ▸ | HTT | P42858 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3144379 | 0.86 | NPC1 (0.55) | NPC1POLBRAB9ASMN1; SMN2LMNA | |
| SCHEMBL4638591 | 0.86 | CES2 (0.59) | CES2CES1CTNNB1WNT3ADRD4 | |
| SCHEMBL4884872 | 0.84 | PDE4B (0.62) | CES2CES1CTNNB1WNT3ADRD4 | |
| SCHEMBL28188567 | 0.84 | PDE4B (0.67) | CES2CES1CTNNB1WNT3ADRD4 | |
| SCHEMBL2379240 | 0.83 | CES2 (0.65) | CES2CES1CTNNB1WNT3ANPC1 | |
| SCHEMBL3302845 | 0.83 | CES2 (0.56) | CES2CES1CTNNB1WNT3ADRD4 | |
| SCHEMBL7315752 | 0.83 | THRA (0.60) | CES2CES1CTNNB1WNT3ADRD4 | |
| SCHEMBL4889161 | 0.83 | CES2 (0.56) | CES2CES1CTNNB1WNT3ADRD4 | |
| SCHEMBL7389569 | 0.83 | CES2 (0.56) | CES2CES1CTNNB1WNT3ADRD4 | |
| SCHEMBL10736335 | 0.83 | THRA (0.60) | CES2CES1CTNNB1WNT3ADRD4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-101203492-B | Substituted butyrophenone derivatives | CLERA INC | 2011-05-04 | — | — | CN | disclosed |
| US-20100004289-A1 | SUBSTITUTED BUTYROPHENONE DERIVATIVES | CLERA INC. (CA) | 2010-01-07 | — | — | US | disclosed |
| EP-1874730-A4 | SUBSTITUTED BUTYROPHENONE DERIVATIVES | CLERA INC (CA) | 2009-06-10 | — | — | EP | disclosed |
| CN-101203492-A | Substituted butyrophenone derivatives | CLERA INC (CA) | 2008-06-18 | — | — | CN | disclosed |
| EP-1874730-A1 | SUBSTITUTED BUTYROPHENONE DERIVATIVES | Clera Inc. (CA) | 2008-01-09 | — | — | EP | disclosed |
| WO-2006116848-A1 | SUBSTITUTED BUTYROPHENONE DERIVATIVES | CLERA INC. (CA) | 2006-11-09 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100004289-A1 | SUBSTITUTED BUTYROPHENONE DERIVATIVES | DBH, SLC6A3, GABBR1 | CES2 1003/4885CES1 3325/4885CTNNB1 4244/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.